P/E at 61.39 vs Industry's 61.54: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: A Near-Perfect Match with Industry P/E

The current P/E of 61.39 for Apollo Hospitals Enterprise Ltd. sits just marginally below the hospital industry average of 61.54. This negligible premium suggests that the market values the company’s earnings on par with its sector peers, reflecting neither an excessive valuation nor a discount. Such parity in valuation is notable given the company’s large-cap status with a market capitalisation of approximately ₹1,11,994 crores.

This valuation alignment contrasts with many large-cap stocks that often trade at significant premiums or discounts relative to their sectors. The near-identical P/E ratio indicates that investors are pricing in similar growth and risk expectations for Apollo Hospitals Enterprise Ltd. as for the broader hospital industry. Apollo Hospitals Enterprise Ltd.’s earnings multiples have remained stable despite recent market volatility, which may prompt the question what is the current rating?

Performance Across Timeframes: Momentum Divergence

Examining returns over multiple periods reveals a compelling story of relative strength and shifting momentum. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a total return of 11.78%, significantly outperforming the Sensex’s negative 3.50% return. This outperformance extends to longer horizons as well, with three-year and five-year returns of 69.26% and 135.19% respectively, more than doubling the Sensex’s 27.63% and 58.36% gains over the same periods.

However, the short-term momentum is equally noteworthy. The stock has gained 8.85% over the past three months, while the Sensex declined by 6.77%. Year-to-date, the stock is up 10.60% compared to the Sensex’s 8.56% loss. Even the one-month and one-week performances show the stock outpacing the broader market, with gains of 6.38% and 1.96% respectively. This consistent outperformance across all measured timeframes highlights the stock’s resilience and relative strength within the hospital sector. Yet, the question remains should investors in Apollo Hospitals Enterprise Ltd. hold, buy more, or reconsider?

Moving Average Configuration: Bullish Technical Setup

The technical picture for Apollo Hospitals Enterprise Ltd. is robust, with the stock trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This configuration typically signals a strong upward trend and suggests that the stock is in a sustained recovery or continuation phase rather than a breakdown or dead-cat bounce.

Trading just 3.45% below its 52-week high of ₹8,099, the stock’s current price of ₹7,829.15 reflects positive investor sentiment and technical momentum. The fact that it outperformed its sector by 0.41% on the latest trading day further reinforces this bullish stance. This technical strength complements the fundamental valuation parity and performance metrics, providing a comprehensive view of the stock’s current market position.

Sector Context: Hospital Industry Performance

The hospital sector has experienced mixed results recently, with a combination of positive, flat, and negative performances among its constituents. Against this backdrop, Apollo Hospitals Enterprise Ltd. stands out for its consistent outperformance. Its ability to maintain a valuation in line with the sector average while delivering superior returns across multiple timeframes suggests a balanced risk-reward profile relative to peers.

Given the sector’s varied performance, the stock’s steady gains and technical strength may be viewed as a stabilising factor. This raises the analytical question is this a genuine recovery or a relief rally that will fade at the 50 DMA? The moving average configuration provides the clearest answer.

Rating Context: Previously Rated Buy, Now Reassessed

On 4 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Buy rating to Hold, reflecting a reassessment of its fundamentals and market position. The Mojo Score stands at 68.0, indicating a solid but not exceptional overall profile. This rating change aligns with the data showing valuation parity with the sector and strong but not extraordinary momentum.

The reassessment invites investors to consider the balance between the stock’s attractive long-term returns and its current valuation and technical setup. This leads to the question what is the current rating? and how it fits within a diversified portfolio strategy.

Conclusion: Data-Driven Insights on Apollo Hospitals Enterprise Ltd.

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a valuation almost identical to its sector peers, with a P/E of 61.39 versus the industry’s 61.54. Its performance across all measured timeframes—from one day to ten years—has consistently outpaced the Sensex, highlighting its relative strength and resilience.

Technically, the stock’s position above all major moving averages and proximity to its 52-week high reinforce a bullish trend. The sector’s mixed results further accentuate the stock’s steady gains and valuation stability. The recent rating reassessment from Buy to Hold reflects a nuanced view balancing these factors.

Collectively, these data points invite investors to carefully weigh the stock’s solid fundamentals and momentum against its valuation and sector dynamics. This leads to the pertinent question should investors in Apollo Hospitals Enterprise Ltd. hold, buy more, or reconsider?

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →